Issues related to development of Epstein-Barr virus vaccines.
Spring
S B
SB
Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
Hascall
G
G
Gruber
J
J
D002051:Burkitt Lymphoma / Q000517:prevention & control / Q000821:virology; D006566:Herpesviridae Infections / Q000517:prevention & control*; D004854:Herpesvirus 4, Human; D006689:Hodgkin Disease / Q000517:prevention & control / Q000821:virology; D006801:Humans; D007244:Infectious Mononucleosis / Q000517:prevention & control / Q000821:virology; D016399:Lymphoma, T-Cell / Q000517:prevention & control / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000517:prevention & control / Q000821:virology; D009303:Nasopharyngeal Neoplasms / Q000517:prevention & control / Q000821:virology; D016377:Organ Transplantation / Q000009:adverse effects; D014412:Tumor Virus Infections / Q000517:prevention & control*; D014765:Viral Vaccines
D014765:Viral Vaccines